NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said second-quarter revenues increased 236 percent as R&D spending rose 44 percent and profit increased over 240 percent.

 

Total receipts for the three months ended June 30 increased to $2.4 billion from $714 million year over year. Last year's results reflect Thermo Electron's operations prior to its merger with Fisher Scientific in November. Including both firm's results from last year, second-quarter revenues increased 9 percent year over year.